Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06411249 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | Clinical Trial |
| Target Enrollment | 350 participants |
| Active Locations | 41 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | November 26, 2025 (Nov 26, 2025) |
As of March 2, 2026: Clinical trial NCT06411249 is currently recruiting participants. This clinical trial study for systemic lupus erythematosus is actively seeking new participants at 41 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06411249 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 41 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06411249 was last updated Nov 26, 2025 (November 26, 2025). HelloStudys verifies this status automatically.